Equipment Upgrade·Capacity Surge｜Hemos Bioscience Accelerates High-Quality Development

 

Recently, Hemos Bioscience's production center successfully completed a new round of equipment upgrades and capacity enhancements. Not only has the overall production capacity increased by more than tenfold, but Hemos has also become the world's first company to achieve scaled-up pilot production, laying a solid foundation for meeting customer demands and upgrading product quality.

 

01. Technological upgrade to solidify the production capacity foundation.

This upgrade covers core production processes and focuses on introducing high-precision equipment such as internationally advanced high-pressure homogenizers, centrifuges, and fermentation tanks. Building upon our existing mature production processes, we’ve established an intelligent control system that enables fine-grained management throughout the entire production chain—from raw materials to finished products. This not only significantly boosts production efficiency but also ensures stability and consistency across product batches.

As production capacity increases, Hemos Bioscience has further accelerated its response speed to regular orders and urgent demands, comprehensively enhancing its supply assurance capabilities.

02. Quality Assurance: Strengthen Quality Control

While expanding production capacity, the company is further strengthening its quality management system and establishing a dual safeguard mechanism of “real-time monitoring + precise testing.”

On the one hand, the new equipment is equipped with an online monitoring system that captures and analyzes production data in real time, enabling precise control of critical process parameters. On the other hand, the laboratory has simultaneously introduced high-precision analytical instruments to conduct rigorous, end-to-end testing of raw materials, semi-finished products, and finished goods, ensuring that all relevant indicators meet internal control standards.

03. Value Delivery, Empowering Customer Growth

The dual enhancement of production capacity and quality ultimately focuses on delivering customer value. A stable supply chain is the key guarantee for advancing customer projects. Following this upgrade, Hemos Bioscience will provide customers with three core supports:

Shorter lead time: Production efficiency has been improved, significantly shortening the order delivery cycle.

More suitable for mass production: With an expanded production capacity, we can easily handle large-volume procurement demands.

More stable quality: Advanced equipment + rigorous quality control ensure consistently high product quality.

Hemos Bioscience has always been centered on “high-quality products + efficient services,” empowering brand owners to build differentiated advantages and achieve value enhancement. We sincerely invite partners from all sectors to join us. Leveraging our upgraded production capacity, we will fully ensure supply stability and on-time order fulfillment, working together to explore new application scenarios for recombinant keratin, co-create new industrial value, and share new industry opportunities.